Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens
Shengle Zhang(Memorial Sloan Kettering Cancer Center), Philip O. Livingston(Memorial Sloan Kettering Cancer Center), Anil Singhal(AbbVie (United States)), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Victor E. Reuter(Memorial Sloan Kettering Cancer Center), H S Zhang(Memorial Sloan Kettering Cancer Center), Kenneth O. Lloyd(Memorial Sloan Kettering Cancer Center)
International Journal of Cancer
September 26, 1997
Cited by 294
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis
|Cell|1996|797
Molecular Cloning of the CA125 Ovarian Cancer Antigen
|Journal of Biological Chemistry|2001|656
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
|The Journal of Experimental Medicine|1982|577